Absorption, Distribution, Metabolism, and Excretion of Therapeutic Proteins: Current Industry Practices and Future Perspectives.

Bolleddula, Jayaprakasam; Brady, Kevin; Bruin, Gerard; Lee, Anthony; Martin, Jennifer A; Walles, Markus; Xu, Keyang; Yang, Tong-Yuan; Zhu, Xiaochun; Yu, Hongbin

Bolleddula, Jayaprakasam; Brady, Kevin; Bruin, Gerard; Lee, Anthony; Martin, Jennifer A; Walles, Markus; Xu, Keyang; Yang, Tong-Yuan; Zhu, Xiaochun; Yu, Hongbin.

Affiliation

Bolleddula J; Quantitative Pharmacology, EMD Serono Research & Development Institute, Inc., Billerica, Massachusetts (J.B.); Quantitative Pharmacology & DMPK, UCB Pharma S.A., Slough, United Kingdom (K.B.); Pharmacokinetic Science, Novartis Institutes for Biomedical Research, Basel, Switzerland (G.B., M.W
Brady K; Quantitative Pharmacology, EMD Serono Research & Development Institute, Inc., Billerica, Massachusetts (J.B.); Quantitative Pharmacology & DMPK, UCB Pharma S.A., Slough, United Kingdom (K.B.); Pharmacokinetic Science, Novartis Institutes for Biomedical Research, Basel, Switzerland (G.B., M.W
Bruin G; Quantitative Pharmacology, EMD Serono Research & Development Institute, Inc., Billerica, Massachusetts (J.B.); Quantitative Pharmacology & DMPK, UCB Pharma S.A., Slough, United Kingdom (K.B.); Pharmacokinetic Science, Novartis Institutes for Biomedical Research, Basel, Switzerland (G.B., M.W
Lee A; Quantitative Pharmacology, EMD Serono Research & Development Institute, Inc., Billerica, Massachusetts (J.B.); Quantitative Pharmacology & DMPK, UCB Pharma S.A., Slough, United Kingdom (K.B.); Pharmacokinetic Science, Novartis Institutes for Biomedical Research, Basel, Switzerland (G.B., M.W
Martin JA; Quantitative Pharmacology, EMD Serono Research & Development Institute, Inc., Billerica, Massachusetts (J.B.); Quantitative Pharmacology & DMPK, UCB Pharma S.A., Slough, United Kingdom (K.B.); Pharmacokinetic Science, Novartis Institutes for Biomedical Research, Basel, Switzerland (G.B., M.W
Walles M; Quantitative Pharmacology, EMD Serono Research & Development Institute, Inc., Billerica, Massachusetts (J.B.); Quantitative Pharmacology & DMPK, UCB Pharma S.A., Slough, United Kingdom (K.B.); Pharmacokinetic Science, Novartis Institutes for Biomedical Research, Basel, Switzerland (G.B., M.W
Xu K; Quantitative Pharmacology, EMD Serono Research & Development Institute, Inc., Billerica, Massachusetts (J.B.); Quantitative Pharmacology & DMPK, UCB Pharma S.A., Slough, United Kingdom (K.B.); Pharmacokinetic Science, Novartis Institutes for Biomedical Research, Basel, Switzerland (G.B., M.W
Yang TY; Quantitative Pharmacology, EMD Serono Research & Development Institute, Inc., Billerica, Massachusetts (J.B.); Quantitative Pharmacology & DMPK, UCB Pharma S.A., Slough, United Kingdom (K.B.); Pharmacokinetic Science, Novartis Institutes for Biomedical Research, Basel, Switzerland (G.B., M.W
Zhu X; Quantitative Pharmacology, EMD Serono Research & Development Institute, Inc., Billerica, Massachusetts (J.B.); Quantitative Pharmacology & DMPK, UCB Pharma S.A., Slough, United Kingdom (K.B.); Pharmacokinetic Science, Novartis Institutes for Biomedical Research, Basel, Switzerland (G.B., M.W
Yu H; Quantitative Pharmacology, EMD Serono Research & Development Institute, Inc., Billerica, Massachusetts (J.B.); Quantitative Pharmacology & DMPK, UCB Pharma S.A., Slough, United Kingdom (K.B.); Pharmacokinetic Science, Novartis Institutes for Biomedical Research, Basel, Switzerland (G.B., M.W

Drug Metab Dispos ; 50(6): 837-845, 2022 06.

Article de En | MEDLINE | ID: mdl-35149541

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Industrie pharmaceutique Type d'étude: Guideline / Prognostic_studies Pays/Région comme sujet: America do norte Langue: En Journal: Drug Metab Dispos Sujet du journal: FARMACOLOGIA Année: 2022 Type de document: Article Pays d'affiliation: Malawi

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google